Summary
125.52 2.24(1.82%)12/12/2025
Abbott Laboratories (ABT)
ABT reported last earnings on 2025-10-15 after the market. An EPS of $1.3 was observed compared to an estimated EPS of $1.3, resulting in a surprise value of $0.00. A revenue of $11,369 million was observed compared to an estimated revenue of $11,390 million, resulting in a surprise value of $-21 Million.
Abbott Laboratories (ABT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 1.82 | -1.55 | -3.04 | -6.75 | -8.16 | 9.93 | 25.95 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | A- |
| Recommended Rating | Buy |
| DCF | Buy |
| ROE | Strong Buy |
| ROA | Strong Buy |
| Debt/Equity | Sell |
| P/E | Sell |
| P/B | Sell |
Earnings
| Trading Data | ||
| Close | 125.52 | |
| Open | 123.47 | |
| High | 125.58 | |
| Low | 122.91 | |
| Volume | 3,327,104 | |
| Change | 2.24 | |
| Change % | 1.82 | |
| Avg Volume (20 Days) | 6,726,960 | |
| Volume/Avg Volume (20 Days) Ratio | 0.49 | |
| 52 Week Range | 109.21 - 139.33 | |
| Price vs 52 Week High | -9.91% | |
| Price vs 52 Week Low | 14.93% | |
| Range | 0.09 | |
| Gap Up/Down | -0.07 | |
Profitibility | ||
| Market Capitalization (Mln) | 218,327 | |
| Revenue per share | 25.0675 | |
| Net Income per share | 7.9914 | |
| Dividend Yield | 0.0191 | |
| Dividend Share | 236.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 15.4234 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
12/12 10:26 EST - prnewswire.com
Abbott increases quarterly dividend for 54th consecutive year
Quarterly dividend increased by 6.8% Quarterly dividend payout has increased more than 70% since 2020 408th consecutive quarterly dividend to be paid by Abbott since 1924 ABBOTT PARK, Ill., Dec. 12, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased...
Abbott increases quarterly dividend for 54th consecutive year
Quarterly dividend increased by 6.8% Quarterly dividend payout has increased more than 70% since 2020 408th consecutive quarterly dividend to be paid by Abbott since 1924 ABBOTT PARK, Ill., Dec. 12, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased...
12/11 14:15 EST - gurufocus.com
Abbott's Billion-Dollar Threat: Pull the Plug or Get a Bailout?
Abbott Laboratories (ABT) is stepping into a moment of rare pressure â and possibly reshaping an entire market in the process. After a jury ordered the compan
Abbott's Billion-Dollar Threat: Pull the Plug or Get a Bailout?
Abbott Laboratories (ABT) is stepping into a moment of rare pressure â and possibly reshaping an entire market in the process. After a jury ordered the compan
12/11 03:45 EST - seekingalpha.com
High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth
The Touchstone Mid Cap Growth Fund outperformed its benchmark, the Russell Midcap® Growth Index, for the quarter ended September 30, 2025. From a factor perspective, the Fund's overweight exposure to size was a relative tailwind to performance, offsetting a headwind from being underweight...
High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth
The Touchstone Mid Cap Growth Fund outperformed its benchmark, the Russell Midcap® Growth Index, for the quarter ended September 30, 2025. From a factor perspective, the Fund's overweight exposure to size was a relative tailwind to performance, offsetting a headwind from being underweight...
12/08 18:50 EST - zacks.com
Here's Why Abbott (ABT) Fell More Than Broader Market
In the latest trading session, Abbott (ABT) closed at $122.09, marking a -2.39% move from the previous day.
Here's Why Abbott (ABT) Fell More Than Broader Market
In the latest trading session, Abbott (ABT) closed at $122.09, marking a -2.39% move from the previous day.
12/08 09:00 EST - prnewswire.com
Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
Lingo, Abbott's first over-the-counter biowearable, expands to Android devices Continuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditions New data from Lingo users highlight how...
Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
Lingo, Abbott's first over-the-counter biowearable, expands to Android devices Continuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditions New data from Lingo users highlight how...
12/07 05:15 EST - defenseworld.net
Cerity Partners LLC Acquires 31,112 Shares of Abbott Laboratories $ABT
Cerity Partners LLC boosted its stake in shares of Abbott Laboratories (NYSE: ABT) by 2.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,538,380 shares of the healthcare product maker's stock after buying an additional 31,112 shares...
Cerity Partners LLC Acquires 31,112 Shares of Abbott Laboratories $ABT
Cerity Partners LLC boosted its stake in shares of Abbott Laboratories (NYSE: ABT) by 2.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,538,380 shares of the healthcare product maker's stock after buying an additional 31,112 shares...
12/06 20:45 EST - prnewswire.com
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community health Second year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors...
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community health Second year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors...
12/05 04:58 EST - defenseworld.net
CW Advisors LLC Has $10.52 Million Stock Position in Abbott Laboratories $ABT
CW Advisors LLC increased its stake in shares of Abbott Laboratories (NYSE: ABT) by 41.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,317 shares of the healthcare product maker's stock after...
CW Advisors LLC Has $10.52 Million Stock Position in Abbott Laboratories $ABT
CW Advisors LLC increased its stake in shares of Abbott Laboratories (NYSE: ABT) by 41.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,317 shares of the healthcare product maker's stock after...
12/05 04:20 EST - defenseworld.net
Beutel Goodman & Co Ltd. Has $3.75 Million Holdings in Abbott Laboratories $ABT
Beutel Goodman and Co Ltd. decreased its stake in shares of Abbott Laboratories (NYSE: ABT) by 20.7% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 27,600 shares of the healthcare product maker's stock after selling 7,198 shares during the...
Beutel Goodman & Co Ltd. Has $3.75 Million Holdings in Abbott Laboratories $ABT
Beutel Goodman and Co Ltd. decreased its stake in shares of Abbott Laboratories (NYSE: ABT) by 20.7% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 27,600 shares of the healthcare product maker's stock after selling 7,198 shares during the...
12/05 02:00 EST - defenseworld.net
Abbott Laboratories (NYSE:ABT) Given Average Rating of “Moderate Buy” by Analysts
Abbott Laboratories (NYSE: ABT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-three analysts that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy...
Abbott Laboratories (NYSE:ABT) Given Average Rating of “Moderate Buy” by Analysts
Abbott Laboratories (NYSE: ABT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the twenty-three analysts that are presently covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy...
12/04 11:00 EST - prnewswire.com
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with two new Ensure Max Protein shakes Ensure Max Protein 42g: For physically active adults, this new...
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with two new Ensure Max Protein shakes Ensure Max Protein 42g: For physically active adults, this new...
12/04 05:46 EST - defenseworld.net
Groupe la Francaise Has $2.12 Million Stake in Abbott Laboratories $ABT
Groupe la Francaise increased its stake in shares of Abbott Laboratories (NYSE: ABT) by 121.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,494 shares of the healthcare product maker's stock after...
Groupe la Francaise Has $2.12 Million Stake in Abbott Laboratories $ABT
Groupe la Francaise increased its stake in shares of Abbott Laboratories (NYSE: ABT) by 121.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,494 shares of the healthcare product maker's stock after...
12/03 10:01 EST - zacks.com
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
12/01 12:48 EST - zacks.com
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
PBH or ABT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
12/01 03:30 EST - defenseworld.net
Boston Family Office LLC Trims Holdings in Abbott Laboratories $ABT
Boston Family Office LLC trimmed its holdings in Abbott Laboratories (NYSE: ABT) by 0.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,564 shares of the healthcare product maker's...
Boston Family Office LLC Trims Holdings in Abbott Laboratories $ABT
Boston Family Office LLC trimmed its holdings in Abbott Laboratories (NYSE: ABT) by 0.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,564 shares of the healthcare product maker's...
11/30 02:05 EST - fool.com
This Top Dividend King Just Became an Even Better Buy
Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative engine.
This Top Dividend King Just Became an Even Better Buy
Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative engine.
11/29 08:02 EST - seekingalpha.com
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW, and ALB, have posted double-digit gains in 2025, while others lag behind. Dividend growth among...
11/29 03:26 EST - defenseworld.net
Balanced Wealth Group LLC Acquires 732 Shares of Abbott Laboratories $ABT
Balanced Wealth Group LLC boosted its holdings in shares of Abbott Laboratories (NYSE: ABT) by 20.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,377 shares of the healthcare product maker's stock...
Balanced Wealth Group LLC Acquires 732 Shares of Abbott Laboratories $ABT
Balanced Wealth Group LLC boosted its holdings in shares of Abbott Laboratories (NYSE: ABT) by 20.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,377 shares of the healthcare product maker's stock...
11/28 04:50 EST - defenseworld.net
Abbott Laboratories $ABT Stock Holdings Lifted by Bank of Nova Scotia Trust Co.
Bank of Nova Scotia Trust Co. lifted its holdings in shares of Abbott Laboratories (NYSE: ABT) by 16.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,218 shares of the healthcare product maker's stock after...
Abbott Laboratories $ABT Stock Holdings Lifted by Bank of Nova Scotia Trust Co.
Bank of Nova Scotia Trust Co. lifted its holdings in shares of Abbott Laboratories (NYSE: ABT) by 16.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 38,218 shares of the healthcare product maker's stock after...
11/28 04:16 EST - defenseworld.net
Abbott Laboratories $ABT Stake Lifted by Clarkston Capital Partners LLC
Clarkston Capital Partners LLC increased its position in shares of Abbott Laboratories (NYSE: ABT) by 15.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,842 shares of...
Abbott Laboratories $ABT Stake Lifted by Clarkston Capital Partners LLC
Clarkston Capital Partners LLC increased its position in shares of Abbott Laboratories (NYSE: ABT) by 15.1% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,842 shares of...
Market News
×
Loading news…